Acasă › Boli pulmonare interstițiale › New York › New York City
Studii clinice pentru Boli pulmonare interstițiale în New York City, NY
18 studii pentru Boli pulmonare interstițiale caută participanți în și în jurul orașului New York City (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
În curs de recrutareFaza 3
- Weill Cornell Medicine-New York-60569, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
În curs de recrutareFaza 3
- Weill Cornell Medicine-New York-60569, New York
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
În curs de recrutareFaza 2
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medicine, New York
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
În curs de recrutareFaza 3
- USA005, New York
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
În curs de recrutareFaza 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
În curs de recrutareFaza 3
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
În curs de recrutareFaza 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
În curs de recrutareFaza 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
În curs de recrutareFaza 2
- Icahn School of Medicine at Mount Sinai, New York
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
În curs de recrutare
- Weill Cornell University Medical College, New York
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
În curs de recrutareFaza 3
- NYU Langone Health, New York
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
În curs de recrutareStudiu observațional
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital - Weill Cornell Medicine, New York
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
În curs de recrutareStudiu observațional
- Weill Cornell Medicine, New York
Platform Clinical Study for Conquering Scleroderma
În curs de recrutareFaza 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
În curs de recrutareFaza 2/3
- Columbia University Irving Medical Center, New York
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
În curs de recrutareStudiu observațional
- Weill Medical College of Cornell University, New York
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
În curs de recrutareFaza 3
- Weill Cornell Medicine, New York-Presbyterian Hospital, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
În curs de recrutareFaza 2
- aTyr Investigative Site, New York
Studii pentru Boli pulmonare interstițiale în alte orașe
- Philadelphia, PA16 studii
- Los Angeles, CA14 studii
- Charleston, SC13 studii
- Kansas City, KS13 studii
- Durham, NC13 studii
- Chicago, IL12 studii
- Houston, TX12 studii
- Aurora, CO11 studii
- Ann Arbor, MI11 studii
- Salt Lake City, UT9 studii
- Dallas, TX9 studii
- Boston, MA9 studii
Alte studii în New York City
- Cancer de sân136 studii
- Cancer pulmonar cu celule non-pătrate121 studii
- Cancer (toate tipurile)109 studii
- Cancer de prostată103 studii
- Cancer metastatic93 studii
- Cancer colorectal78 studii
- Cancer ovarian69 studii
- Cancer pulmonar60 studii
- Mielom multiplu60 studii
- Cancer pancreatic60 studii
- Cancer endometrial52 studii
- Leucemie mieloasă acută51 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.